Related Experiment Video
Updated: Aug 13, 2025

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Harm! foul! How acute kidney injury SHReDDs patient futures
Jessica F Hebert1, Yoshio Funahashi1, Michael P Hutchens1,2
1Department of Anesthesiology & Perioperative Medicine, Oregon Health and Science University.
Purpose Of Review:
Transition from acute kidney injury (AKI) to chronic kidney disease (CKD) is increasingly accepted. Less well recognized, but supported by very similar data, is development of disease of other organ systems after AKI. Awareness of other-organ sequelae of AKI may inform efforts to improve the care of patients after AKI.
Recent Findings:
Stroke, hypertension, reproductive risk, dementia, and death (SHReDD) are sequelae, which occur with increased risk relative to that of non-AKI within 6 months-3 years after AKI diagnosis, and which are supported by preclinical/mechanistic study. Adjusted hazard ratios for these sequelae are strikingly similar to that of AKI-CKD, ranging from 1.2 to 3.0. Mechanistic studies suggest kidney-centric mechanisms including sodium regulation, volume status regulation, and the renin-angiotensin system are drivers of long-term, extra-renal, change.
Summary:
Further clinical characterization and mechanistic insight is necessary, and may have considerable translational impact. Programs which screen or follow post-AKI patients may increase clinical utility if focus is expanded to include the SHReDD complications.
Insights
Acute kidney injury (AKI) can lead to chronic kidney disease (CKD) and other organ damage, including stroke, hypertension, and dementia. Early recognition of these long-term complications is crucial for patient care.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Neurology
Background:
- The transition from acute kidney injury (AKI) to chronic kidney disease (CKD) is well-established.
- Emerging evidence suggests AKI also increases the risk of developing diseases in other organ systems.
- Understanding these extra-renal sequelae is critical for comprehensive patient management post-AKI.
Approach:
- Review of clinical data and preclinical studies investigating long-term outcomes after AKI.
- Analysis of hazard ratios for various post-AKI complications, including stroke, hypertension, reproductive risk, dementia, and death (SHReDD).
- Exploration of kidney-centric mechanisms, such as sodium and volume regulation, and the renin-angiotensin system, implicated in extra-renal disease development.
Key Points:
- Patients diagnosed with AKI face an increased risk of SHReDD complications within 6 months to 3 years.
- The adjusted hazard ratios for these SHReDD sequelae are comparable to those observed for AKI-CKD progression (ranging from 1.2 to 3.0).
- Mechanistic studies implicate renal regulatory systems in driving long-term extra-renal pathologies.
Conclusions:
- Further clinical and mechanistic research is needed to fully elucidate the links between AKI and other organ system diseases.
- Expanding post-AKI patient screening and follow-up protocols to include SHReDD complications can enhance clinical utility and patient outcomes.
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury II: Pathophysiology

